Related Experiment Videos
Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the
1Massachusetts General Hospital, Charlestown 02129.
Immunological Reviews
|April 1, 1990
Summary
Leu-Cellular Adhesion Molecule (Leu-CAM) deficiency highlights the critical role of leukocyte adhesion molecules in inflammation. Genetic defects in CD18 impair cell function, offering insights into controlling inflammatory responses.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Leu-Cellular Adhesion Molecule (Leu-CAM) deficiency is a rare inherited disorder.
- This condition underscores the importance of leukocyte adhesion molecules in inflammatory processes.
- It reveals the complex cell interactions required for leukocyte mobilization to infection sites.
Purpose of the Study:
- To understand the molecular basis of Leu-CAM deficiency.
- To elucidate the role of CD11/CD18 adhesion molecules in leukocyte function.
- To explore novel therapeutic strategies for controlling inflammation.
Main Methods:
- Analysis of inherited single amino acid substitutions in CD18.
- Investigation of CD18 phosphorylation and its regulation.
- In vitro studies using anti-CD11/CD18 monoclonal antibodies.
Main Results:
- Identified specific CD18 mutations impairing heterodimer formation and cell surface expression, causing Leu-CAM deficiency.
- Demonstrated stimulus-induced, transient phosphorylation of CD18, potentially regulating receptor function.
- Highlighted the greater importance of CD11/CD18 for phagocytic cells compared to lymphocytes.
Conclusions:
- Genetic defects in CD18 are the primary cause of Leu-CAM deficiency.
- Understanding CD11/CD18 regulation offers new avenues for managing inflammatory diseases.
- The study provides insights into controlling inflammation when it becomes detrimental.